Search Results

There are 25075 results for: content related to: Botulinum toxin modulates basal ganglia but not deficient somatosensory activation in orofacial dystonia

  1. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion

    Acta Neurologica Scandinavica

    Volume 117, Issue 2, February 2008, Pages: 73–84, E. C.-H. Lim and R. C. S. Seet

    Version of Record online : 11 SEP 2007, DOI: 10.1111/j.1600-0404.2007.00931.x

  2. You have free access to this content
    Evidence for CALM in Directing VAMP2 Trafficking

    Traffic

    Volume 9, Issue 3, March 2008, Pages: 417–429, Asaff Harel, Fangbai Wu, Mark P. Mattson, Christa M. Morris and Pamela J. Yao

    Version of Record online : 21 DEC 2007, DOI: 10.1111/j.1600-0854.2007.00694.x

  3. Long-term performance of co-metabolic degradation of trichloroethylene in a fluidized bed reactor fed with benzene, toluene and xylene

    Journal of Chemical Technology and Biotechnology

    Volume 83, Issue 4, April 2008, Pages: 513–523, Wei-Min Wu, Jing Shi and Robert F Hickey

    Version of Record online : 5 FEB 2008, DOI: 10.1002/jctb.1826

  4. Botulinum toxins in neurological disease

    Muscle & Nerve

    Volume 29, Issue 5, May 2004, Pages: 628–644, Cynthia L. Comella and Seth L. Pullman

    Version of Record online : 12 APR 2004, DOI: 10.1002/mus.20033

  5. You have free access to this content
    Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction

    Intervention Review

    The Cochrane Library

    Elaine Utomo, Jan Groen and Bertil FM Blok

    Published Online : 24 MAY 2014, DOI: 10.1002/14651858.CD004927.pub4

  6. Comparison of Botulinum Toxins A and B in the Aesthetic Treatment of Facial Rhytides

    Dermatologic Surgery

    Volume 29, Issue 4, April 2003, Pages: 340–347, Neil S. Sadick and Alysa R. Herman

    Version of Record online : 26 MAR 2003, DOI: 10.1046/j.1524-4725.2003.29082.x

  7. Botulinum Toxin: Basic Science and Clinical Uses in Otolaryngology

    The Laryngoscope

    Volume 111, Issue 2, February 2001, Pages: 218–226, Andrew Blitzer and Lucian Sulica

    Version of Record online : 2 JAN 2009, DOI: 10.1097/00005537-200102000-00006

  8. Effects of botulinum toxin type A on non-injected bi-articular muscle include a narrower length range of force exertion and increased passive force

    Muscle & Nerve

    Volume 49, Issue 6, June 2014, Pages: 866–878, Filiz Ateş and Can A. Yucesoy

    Version of Record online : 17 MAY 2014, DOI: 10.1002/mus.23993

  9. RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 1, January 2013, Pages: e1–e7, D.H. Lee, S.M. Kang, A. Feneran, C.S. Youn, J.K. Kim, S. Cho, C.H. Won, S.E. Chang, M.W. Lee, J.H. Choi and K.C. Moon

    Version of Record online : 3 OCT 2012, DOI: 10.1111/j.1468-3083.2012.04681.x

  10. Treatment of cervical dystonia with botulinum toxin

    Movement Disorders

    Volume 19, Issue S8, March 2004, Pages: S109–S115, Joseph Jankovic

    Version of Record online : 9 MAR 2004, DOI: 10.1002/mds.20024

  11. You have free access to this content
    Effect of botulinum toxin A-induced paralysis and exercise training on mechanosensing and signalling gene expression in juvenile rat gastrocnemius muscle

    Experimental Physiology

    Volume 93, Issue 12, December 2008, Pages: 1273–1283, Martina Velders, Kirsten Legerlotz, Shelley J. Falconer, N. Susan Stott, Christopher D. McMahon and Heather K. Smith

    Version of Record online : 29 AUG 2008, DOI: 10.1113/expphysiol.2008.043174

  12. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation

    European Journal of Neurology

    Volume 8, Issue s5, November 2001, Pages: 194–202, J. Houltram, I. Noble, R. N. Boyd, I. Corry, P. Flett and H. K. Graham

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00052.x

  13. You have full text access to this OnlineOpen article
    Botulinum toxin type A for neuropathic pain in patients with spinal cord injury

    Annals of Neurology

    Volume 79, Issue 4, April 2016, Pages: 569–578, Zee-A Han, Dae Heon Song, Hyun-Mi Oh and Myung Eun Chung

    Version of Record online : 16 FEB 2016, DOI: 10.1002/ana.24605

  14. Engineering neuronal nicotinic acetylcholine receptors with functional sensitivity to α-bungarotoxin: a novel α3-knock-in mouse

    European Journal of Neuroscience

    Volume 30, Issue 11, December 2009, Pages: 2064–2076, Philip M. Caffery, Arjun Krishnaswamy, Tanya Sanders, Jing Liu, Hilary Hartlaub, Jan Klysik, Ellis Cooper and Edward Hawrot

    Version of Record online : 25 NOV 2009, DOI: 10.1111/j.1460-9568.2009.07016.x

  15. You have free access to this content
    Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study

    The Journal of Dermatology

    Volume 43, Issue 1, January 2016, Pages: 56–62, Sei-ichiro Motegi, Kazuya Yamada, Sayaka Toki, Akihiko Uchiyama, Yuka Kubota, Tetsuya Nakamura and Osamu Ishikawa

    Version of Record online : 15 JUL 2015, DOI: 10.1111/1346-8138.13030

  16. Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain

    Annals of Neurology

    Volume 64, Issue 3, 28 September 2008, Pages: 274–283, Danièle Ranoux, Nadine Attal, Francoise Morain and D. Bouhassira

    Version of Record online : 10 JUN 2008, DOI: 10.1002/ana.21427

  17. Safety and efficacy of multiuse botulinum toxin vials for intralaryngeal injection

    The Laryngoscope

    Volume 125, Issue 5, May 2015, Pages: 1149–1154, Emily M. Barrow, Clark A. Rosen, Edie R. Hapner, Sarah Smith, Jeanne L. Hatcher, Blake Simpson and Michael M. Johns III

    Version of Record online : 4 DEC 2014, DOI: 10.1002/lary.25068

  18. You have free access to this content
    Patients’ perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury

    BJU International

    Volume 104, Issue 2, July 2009, Pages: 216–220, Satoshi Hori, Prasad Patki, Kaka H. Attar, Soran Ismail, Joana C. Vasconcelos and P. Julian R. Shah

    Version of Record online : 10 FEB 2009, DOI: 10.1111/j.1464-410X.2009.08368.x

  19. Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences

    European Journal of Neurology

    Volume 8, Issue s5, November 2001, Pages: 88–97, G. Molenaers, K. Desloovere, J. De Cat, I. Jonkers, L. De Borre, P. Pauwels, J. Nijs, G. Fabry and P. De Cock

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1468-1331.2001.00041.x

  20. Botulinum Toxin Type B (Myobloc)

    Dermatologic Surgery

    Volume 29, Issue 5, May 2003, Pages: 496–500, Leslie Baumann and Laura Black

    Version of Record online : 6 MAY 2003, DOI: 10.1046/j.1524-4725.2003.29120.x